Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • TinySci
    Junior Member
    • May 2015
    • 5

    Adding BLAST+ to Python PATH

    Very new to bioinformatics and I am trying to write a code that will allow me to use a reference geneset (e.g. MLST) and BLAST it against genomes available on Genbank so that I can create datasets of these genesets.

    For example, if I wish to do a multi locus gene comparison for a given genus, I'd like to be able to input my reference gene set, BLAST it against the available genomes and pull the gene sequences (fasta) that match with X% ID from the genome.

    The reason I thought to do a BLAST-extraction is because some of the genomes I'm looking through are not annotated.

    My idea is to use the BLAST+ tools to do this, but I cannot call the module in python. I've downloaded the software, but can only call it in terminal (I am using a mac). I am using python 2.7.5 and have added numpy and biopython.

    Could anyone provide some advice for a novice?

    Thanks in advance!
  • LeightonP
    Member
    • Feb 2011
    • 29

    #2
    There are a number of options open to you. One of which is to use code that others have written and tested (always a decent first option!). BIGSdb may be useful for you (http://pubmlst.org/software/database/bigsdb/). If you have access to a local Galaxy instance, there may be an MLST workflow available to you. If you're using pubMLST-compatible definitions, then this Python script https://github.com/widdowquinn/scrip...cs/run_MLST.py might do what you want, or serve as an example you can build from.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    213 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    79 views
    0 reactions
    Last Post SEQadmin2  
    Working...